The company's portable and cost-effective device uses electrochemical biosensors to quickly and accurately detect infectious disease-related biomarkers in saliva, providing quantitative analytical and diagnostic results in just five minutes for under $35 per test. Foothold Labs aims to develop a next-generation rapid diagnostic platform for point-of-care healthcare applications and has already secured partnerships with prestigious institutions such as the Naval Research Laboratory, MIT Chemistry, and the University of Kansas Bioengineering program. The company has also received over $1.5MM in SBIR grant funding from the US Air Force and US Special Operations Command in the last year.